„Vierundzwanzigsieben“ – Neuer Klinik-Podcast aus Bielefeld: Mitarbeitende geben spannende Einblicke

AKTUELLES

Das Evangelische Klinikum Bethel (EvKB) und das Krankenhaus Mara in Bielefeld gehen mit einem neuen Podcast auf Sendung: „Vierundzwanzigsieben“ gibt…

» mehr erfahren

Bei Beschwerden der Nervenbahnen, des Gehirns, des Rückenmarks und der Muskulatur sind wir die Spezialisten in Ostwestfalen-Lippe. Wir arbeiten fachübergreifend und Hand in Hand. So finden wir schnell und gezielt die richtige Behandlung für Ihre Erkrankung.

Neurologie

Herzlich willkommen!

Schwindel, Kopfschmerzen, unklare Bewusstseins-, Sprach-, Seh-, Bewegungs- oder Sensibilitätsstörungen können bei Betroffenen oft Ängste und Unsicherheit auslösen. Sie vermitteln das Gefühl, nicht mehr Herr seiner selbst zu sein und die Betroffenen fragen sich: „Was stimmt nicht mit mir?“ Unsere Universitätsklinik für Neurologie – auch Nervenheilkunde genannt – im Haus Gilead I hilft Ihnen, Antworten zu finden – und die richtige Therapie.

In ganz Ostwestfalen-Lippe sind wir der Hauptansprechpartner bei neurologischen Fragen und Erkrankungen. Alle Erkrankungen des Nervensystems werden hier diagnostiziert und behandelt.

Forschung und Lehre

Ansprechpartner

Ansprechpartner für Forschung, Lehre, Praktisches Jahr

Univ.-Prof. Dr. med. Wolf-Rüdiger Schäbitz

Lehrbeauftragter, Forschungsbeauftragter, Beauftragter für das Praktische Jahr, Chefarzt

Tel: 0521 772-78301

neurologie@evkb.de

Dorothe Spieker

Schlaganfall-Lotsin

dorothe.spieker@evkb.de

Weiterbildung

Ärztliche Weiterbildung

Facharztweiterbildung Neurologie	48 Monate
Facharztzusatzweiterbildung Schlafmedizin	18 Monate
Weiterbildung Klinische Neuropsychologie GNP (Gesellschaft für Neuropsychologie)	36 Monate (In Zusammenarbeit mit der Klinik für Psychiatrie und Psychotherapie – Prof. Dr. rer. nat. Thomas Beblo)

Forschungsprojekte

Aktuelle Studien

Vorhofflimmern bei Patienten mit einem implantierbaren Eventrekorder nach einem akuten embolischen Schlaganfall unbekannter Ursache (ESUS)
RE-SPECT ESUS
RASUNOA-Prime
PRODAST
Kardiovaskuläre Risikofaktoren und mögliche Implikationen für eine Sekundärprophylaxe der transienten globalen Amnesie

Veröffentlichungen

Veröffentlichungen aus unserer Klinik

Ganulocyte-Colony Stimulating Factor (G-CSF) in Stroke Patients with Concomitant Vascular Disease-A Randomized Controlled Trial. Floel A, Warnecke T, Duning T, Lating Y, Uhlenbrock J, Schneider A, Vogt G, Laage R, Koch W, Knecht S, Schäbitz WR. PLoS One. 2011;6(5):e19767. Epub 2011 May 23.
[Treatment of neuro-AIDS on a neurological intensive care unit : Epidemiology and predictors of outcome.] Braicks O, Anneken K, Reichelt D, Schäbitz WR, Dziewas R, Evers S, Husstedt IW. Nervenarzt. 2011 May 14. [Epub ahead of print] German
Effects of neural progenitor cells on sensorimotor recovery and endogenous repair mechanisms after photothrombotic stroke. Minnerup J, Kim JB, Schmidt A, Diederich K, Bauer H, Schilling M, Strecker JK, Ringelstein EB, Sommer C, Schöler HR, Schäbitz WR. Stroke. 2011 Jun;42(6):1757-63. Epub 2011 May 12.
G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial. Duning T, Schiffbauer H, Warnecke T, Mohammadi S, Floel A, Kolpatzik K, Kugel H, Schneider A, Knecht S, Deppe M, Schäbitz WR. PLoS One. 2011 Mar 14;6(3):e17770.
Erythropoietin for stroke treatment: dead or alive? Minnerup J, Wersching H, Schäbitz WR. Crit Care. 2011 Mar 9;15(2):129. [Epub ahead of print]
Sodium-dependent vitamin C transporter 2 (SVCT2) expression and activity in brain capillary endothelial cells after transient ischemia in mice. Gess B, Sevimli S, Strecker JK, Young P, Schäbitz WR. PLoS One. 2011 Feb 11;6(2):e17139.
[Juvenile pontine infarction. Complication of acute posterior multifocal placoid pigment epitheliopathy]. Poppenborg M, Schäbitz W, Rauch M, Spital G. Nervenarzt. 2011 Apr;82(4):496, 498-9. German. No abstract available.
Seeing old friends from a different angle: Novel properties of hematopoietic growth factors in the healthy and diseased brain. Diederich K, Schäbitz WR, Minnerup J. Hippocampus. 2010 Dec 6. [Epub ahead of print]
AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.
Schäbitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S, Schneider D, Hamann GF, Rosenkranz M, Veltkamp R, Fiebach JB, Hacke W, Grotta JC, Fisher M, Schneider A. Stroke. 2010 Nov;41(11):2545-51. Epub 2010 Oct 14.
Late Onset Postpartum Eclampsia: It is Really Never Too Late-A Case of Eclampsia 8 Weeks after Delivery. Minnerup J, Kleffner I, Wersching H, Zimmermann J, Schäbitz WR, Niederstadt T, Dziewas R. Stroke Res Treat. 2010;2010. pii: 798616. Epub 2009 Sep 1.
Investigation of neuronal progenitor cell origin after transient focal cerebral ischemia in mice. Strecker JK, Minnerup J, Sevimli S, Ringelstein EB, Schäbitz WR, Schilling M. Neurosci Res. 2010 Nov;68(3):256-9. Epub 2010 Aug 11.
Methodological quality of preclinical stroke studies is not required for publication in high-impact journals. Minnerup J, Wersching H, Diederich K, Schilling M, Ringelstein EB, Wellmann J, Schäbitz WR. J Cereb Blood Flow Metab. 2010 Sep;30(9):1619-24. Epub 2010 Jun 2.
Semaphorin 6A improves functional recovery in conjunction with motor training after cerebral ischemia. Rogalewski A, Dittgen T, Klugmann M, Kirsch F, Krüger C, Pitzer C, Minnerup J, Schäbitz WR, Schneider A. PLoS One. 2010 May 20;5(5):e10737.
EPO for stroke therapy - Is there a future for further clinical development? Minnerup J, Wersching H, Schäbitz WR. Exp Transl Stroke Med. 2010 May 12;2(1):10.
[Clinical relevance of normal and enlarged Virchow-Robin spaces]. Gess B, Niederstadt TU, Ringelstein EB, Schäbitz WR. Nervenarzt. 2010 Jun;81(6):727-33. Review. German.
Effects of granulocyte-colony stimulating factor after stroke in aged rats. Popa-Wagner A, Stöcker K, Balseanu AT, Rogalewski A, Diederich K, Minnerup J, Margaritescu C, Schäbitz WR. Stroke. 2010 May;41(5):1027-31. Epub 2010 Apr 1.
Intracarotid administration of human bone marrow mononuclear cells in rat photothrombotic ischemia. Minnerup J, Seeger FH, Kuhnert K, Diederich K, Schilling M, Dimmeler S, Schäbitz WR. Exp Transl Stroke Med. 2010 Feb 2;2(1):3.
Darbepoetin alfa and chronic kidney disease. Minnerup J, Schäbitz WR. N Engl J Med. 2010 Feb 18;362(7):653-4; author reply 655. No abstract available.
Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies. Minnerup J, Sevimli S, Schäbitz WR. Exp Transl Stroke Med. 2009 Oct 21;1:2.
Time to overcome the translational roadblock: Introducing a new open access stroke journal. Schäbitz WR, Kleinschnitz C. Exp Transl Stroke Med. 2009 Oct 21;1:1. No abstract available.
Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Dengler R, Diener HC, Schwartz A, Grond M, Schumacher H, Machnig T, Eschenfelder CC, Leonard J, Weissenborn K, Kastrup A, Haberl R; EARLY Investigators. Lancet Neurol. 2010 Feb;9(2):159-66. Epub 2010 Jan 7.
Effects of G-CSF treatment on neutrophil mobilization and neurological outcome after transient focal ischemia. Strecker JK, Sevimli S, Schilling M, Klocke R, Nikol S, Schneider A, Schäbitz WR. Exp Neurol. 2010 Mar;222(1):108-13. Epub 2009 Dec 21.
The role of granulocyte-colony stimulating factor (G-CSF) in the healthy brain: a characterization of G-CSF-deficient mice. Diederich K, Sevimli S, Dörr H, Kösters E, Hoppen M, Lewejohann L, Klocke R, Minnerup J, Knecht S, Nikol S, Sachser N, Schneider A, Gorji A, Sommer C, Schäbitz WR. J Neurosci. 2009 Sep 16;29(37):11572-81.
The impact of lesion location and lesion size on poststroke infection frequency. Minnerup J, Wersching H, Brokinkel B, Dziewas R, Heuschmann PU, Nabavi DG, Ringelstein EB, Schäbitz WR, Ritter MA. J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):198-202. Epub 2009 Sep 2.
Turn-over of meningeal and perivascular macrophages in the brain of MCP-1-, CCR-2- or double knockout mice. Schilling M, Strecker JK, Ringelstein EB, Kiefer R, Schäbitz WR. Exp Neurol. 2009 Oct;219(2):583-5. Epub 2009 Jul 15.
The role of CC chemokine receptor 2 on microglia activation and blood-borne cell recruitment after transient focal cerebral ischemia in mice. Schilling M, Strecker JK, Ringelstein EB, Schäbitz WR, Kiefer R. Brain Res. 2009 Sep 15;1289:79-84. Epub 2009 Jun 24.
The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis. Minnerup J, Heidrich J, Rogalewski A, Schäbitz WR, Wellmann J. Stroke. 2009 Sep;40(9):3113-20. Epub 2009 Jun 18. Review.
MR mismatch is useful for patient selection for thrombolysis: no. Schäbitz WR. Stroke. 2009 Aug;40(8):2908-9. Epub 2009 Jun 4. Review. No abstract available.
Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M; STAIR VI Consortium. Stroke. 2009 Jul;40(7):2594-600. Epub 2009 May 28.
Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus. Möddel G, Bunten S, Dobis C, Kovac S, Dogan M, Fischera M, Dziewas R, Schäbitz WR, Evers S, Happe S. J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):689-92.
Synergetic effects of granulocyte-colony stimulating factor and cognitive training on spatial learning and survival of newborn hippocampal neurons. Diederich K, Schäbitz WR, Kuhnert K, Hellström N, Sachser N, Schneider A, Kuhn HG, Knecht S. PLoS One. 2009;4(4):e5303. Epub 2009 Apr 24.
Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Schilling M, Strecker JK, Schäbitz WR, Ringelstein EB, Kiefer R. Neuroscience. 2009 Jul 7;161(3):806-12. Epub 2009 Apr 15.
[Acute polyneuritis and polyradiculoneuritis: uncommon causes and their pathomechanisms]. Duning T, Kraus J, Schäbitz WR. Fortschr Neurol Psychiatr. 2009 Apr;77(4):218-27. Epub 2009 Apr 3. Review. German.
Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Sevimli S, Diederich K, Strecker JK, Schilling M, Klocke R, Nikol S, Kirsch F, Schneider A, Schäbitz WR. Exp Neurol. 2009 Jun;217(2):328-35. Epub 2009 Mar 28.
Towards a basic endoscopic evaluation of swallowing in acute stroke - identification of salient findings by the inexperienced examiner. Warnecke T, Teismann I, Oelenberg S, Hamacher C, Ringelstein EB, Schäbitz WR, Dziewas R. BMC Med Educ. 2009 Mar 10;9:13.
Update of the stroke therapy academic industry roundtable preclinical recommendations. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH; STAIR Group. Stroke. 2009 Jun;40(6):2244-50. Epub 2009 Feb 26. Review.
Different postischemic protein expression of the GABA(A) receptor alpha2 subunit and the plasticity-associated protein MAP1B after treatment with BDNF versus G-CSF in the rat brain. Müller HD, Neder A, Sommer C, Schäbitz WR. Restor Neurol Neurosci. 2009;27(1):27-39.
Multifunctional actions of approved and candidate stroke drugs. Minnerup J, Schäbitz WR. Neurotherapeutics. 2009 Jan;6(1):43-52. Review.
Dilemmas in the management of atrial fibrillation in chronic kidney disease. Reinecke H, Brand E, Mesters R, Schäbitz WR, Fisher M, Pavenstädt H, Breithardt G. J Am Soc Nephrol. 2009 Apr;20(4):705-11. Epub 2008 Dec 17. Review.
The safety of fiberoptic endoscopic evaluation of swallowing in acute stroke patients. Warnecke T, Teismann I, Oelenberg S, Hamacher C, Ringelstein EB, Schäbitz WR, Dziewas R. Stroke. 2009 Feb;40(2):482-6. Epub 2008 Dec 12.
Development of a mycotic aneurysm within 4 days. Minnerup J, Schilling M, Wersching H, Olschläger C, Schäbitz WR, Niederstadt T, Dziewas R. Neurology. 2008 Nov 18;71(21):1745. No abstract available.
Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Schäbitz WR, Schneider A, Laage R. Neurology. 2008 Oct 28;71(18):1461; author reply 1461. No abstract available.
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Pitzer C, Krüger C, Plaas C, Kirsch F, Dittgen T, Müller R, Laage R, Kastner S, Suess S, Spoelgen R, Henriques A, Ehrenreich H, Schäbitz WR, Bach A, Schneider A. Brain. 2008 Dec;131(Pt 12):3335-47. Epub 2008 Oct 3.
Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia. Schomacher M, Müller HD, Sommer C, Schwab S, Schäbitz WR. Brain Res. 2008 Nov 13;1240:213-20. Epub 2008 Sep 18.
Practical and comprehensive approaches to evaluating stroke patients: today and tomorrow. Schäbitz WR, Günther Nabavi D. Handb Clin Neurol. 2009;94:1119-25. No abstract available.
Old friends in new constellations - the hematopoetic growth factors G-CSF, GM-CSF, and EPO for the treatment of neurological diseases. Maurer MH, Schäbitz WR, Schneider A. Curr Med Chem. 2008;15(14):1407-11. Review.
Towards a basic endoscopic assessment of swallowing in acute stroke - development and evaluation of a simple dysphagia score. Dziewas R, Warnecke T, Olenberg S, Teismann I, Zimmermann J, Kramer C, Ritter M, Ringelstein EB, Schabitz WR. Cerebrovasc Dis. 2008;26(1):41-7. Epub 2008 May 30.
Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro. Kraus J, Voigt K, Schuller AM, Scholz M, Kim KS, Schilling M, Schäbitz WR, Oschmann P, Engelhardt B. Mult Scler. 2008 Jul;14(6):843-52. Epub 2008 May 27.
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T; FAST Trial Investigators. N Engl J Med. 2008 May 15;358(20):2127-37.
Positional sleep apnea in patients with ischemic stroke. Dziewas R, Hopmann B, Humpert M, Ritter M, Dittrich R, Schäbitz WR, Ringelstein EB, Nabavi DG, Young P. Neurol Res. 2008 Jul;30(6):645-8. Epub 2008 Apr 18.
Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia. Minnerup J, Heidrich J, Wellmann J, Rogalewski A, Schneider A, Schäbitz WR. Stroke. 2008 Jun;39(6):1855-61. Epub 2008 Apr 10.'
Granulocyte colony-stimulating factor (G-CSF) for cardio- and cerebrovascular regenerative applications. Klocke R, Kuhlmann MT, Scobioala S, Schäbitz WR, Nikol S. Curr Med Chem. 2008;15(10):968-77. Review.
Wheel-running in a transgenic mouse model of Alzheimer's disease: protection or symptom? Richter H, Ambrée O, Lewejohann L, Herring A, Keyvani K, Paulus W, Palme R, Touma C, Schäbitz WR, Sachser N. Behav Brain Res. 2008 Jun 26;190(1):74-84. Epub 2008 Feb 8.
The role of aquaporin-4 polymorphisms in the development of brain edema after middle cerebral artery occlusion. Kleffner I, Bungeroth M, Schiffbauer H, Schäbitz WR, Ringelstein EB, Kuhlenbäumer G. Stroke. 2008 Apr;39(4):1333-5. Epub 2008 Feb 28.
A Critique of SAINT II: wishful thinking, dashed hopes, and the future of neuroprotection for acute stroke. Savitz SI, Schäbitz WR. Stroke. 2008 Apr;39(4):1389-91. Epub 2008 Feb 28. Review. No abstract available.
Assessment of aspiration risk in acute ischaemic stroke--evaluation of the simple swallowing provocation test. Warnecke T, Teismann I, Meimann W, Olenberg S, Zimmermann J, Krämer C, Ringelstein EB, Schäbitz WR, Dziewas R. J Neurol Neurosurg Psychiatry. 2008 Mar;79(3):312-4.
Brain-derived neurotrophic factor but not forced arm use improves long-term outcome after photothrombotic stroke and transiently upregulates binding densities of excitatory glutamate receptors in the rat brain. Müller HD, Hanumanthiah KM, Diederich K, Schwab S, Schäbitz WR, Sommer C. Stroke. 2008 Mar;39(3):1012-21. Epub 2008 Jan 31.
[Development of new stroke therapies: outlook for neuroprotective drugs]. Rogalewski A, Schäbitz WR. Nervenarzt. 2008 Feb;79(2):218-24. German.
Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease. Ambrée O, Richter H, Sachser N, Lewejohann L, Dere E, de Souza Silva MA, Herring A, Keyvani K, Paulus W, Schäbitz WR. Neurobiol Aging. 2009 Aug;30(8):1192-204. Epub 2008 Feb 20.
Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis. Rogalewski A, Kraus J, Hasselblatt M, Kraemer C, Schäbitz WR. Neuropsychiatr Dis Treat. 2007 Dec;3(6):987-91.
The hematopoietic factor GM-CSF (granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro. Krüger C, Laage R, Pitzer C, Schäbitz WR, Schneider A. BMC Neurosci. 2007 Oct 22;8:88.
Serial fiberoptic endoscopic evaluation of swallowing in patients with acute stroke and dysphagia: case report and general considerations. Warnecke T, Dziewas R, Oelenberg S, Ritter M, Dittrich R, Schäbitz WR, Ringelstein EB, Nabavi DG. J Stroke Cerebrovasc Dis. 2006 Jul-Aug;15(4):172-5.
C-reactive protein and fibrinogen in acute stroke patients with and without sleep apnea. Dziewas R, Ritter M, Kruger L, Berger S, Langer C, Kraus J, Dittrich R, Schabitz WR, Ringelstein EB, Young P. Cerebrovasc Dis. 2007;24(5):412-7. Epub 2007 Sep 19.
A case of idiopathic basal ganglia calcification presenting with only acting-out attacks and mild cognitive impairment: PET findings. Yulug B, Bakar M, Karapolat I, Güzel O, Schäbitz WR. J Neuropsychiatry Clin Neurosci. 2007 Summer;19(3):348-9. No abstract available.
Topiramate improves glucose metabolism in choreatic and depressive patient: PET findings. Yulug B, Bakar M, Karapolat I, Güzel O, Schäbitz WR. J Neuropsychiatry Clin Neurosci. 2007 Summer;19(3):346-7. No abstract available.
Atherosclerosis and obstructive sleep apnea in patients with ischemic stroke. Dziewas R, Ritter M, Usta N, Boentert M, Hor H, Dittrich R, Schäbitz WR, Ringelstein EB, Young P. Cerebrovasc Dis. 2007;24(1):122-6. Epub 2007 Jun 11.
Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Schäbitz WR, Steigleder T, Cooper-Kuhn CM, Schwab S, Sommer C, Schneider A, Kuhn HG. Stroke. 2007 Jul;38(7):2165-72. Epub 2007 May 17.
A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). Schäbitz WR, Krüger C, Pitzer C, Weber D, Laage R, Gassler N, Aronowski J, Mier W, Kirsch F, Dittgen T, Bach A, Sommer C, Schneider A. J Cereb Blood Flow Metab. 2008 Jan;28(1):29-43. Epub 2007 Apr 25.
CRMP-5-autoantibodies in testicular cancer associated with limbic encephalitis and choreiform dyskinesias. Kellinghaus C, Kraus J, Blaes F, Nabavi DG, Schäbitz WR. Eur Neurol. 2007;57(4):241-3. Epub 2007 Mar 26. No abstract available.
New targets for established proteins: exploring G-CSF for the treatment of stroke. Schäbitz WR, Schneider A. Trends Pharmacol Sci. 2007 Apr;28(4):157-61. Epub 2007 Mar 12.
Temporal coincidence between AMAN type of GBS and myasthenia gravis. Kraus J, Teismann I, Kellinghaus C, Duning T, Ringelstein EB, Nabavi DG, Schäbitz WR. J Neurol. 2007 Feb;254(2):264-5. Epub 2007 Feb 17. No abstract available.
[Treatment strategies for tetanus]. Duning T, Schäbitz WR. Nervenarzt. 2007 Feb;78(2):145-6, 149-52, 155. Review. German.
Olanzapine attenuates brain damage after focal cerebral ischemia in vivo. Yulug B, Yildiz A, Hüdaoglu O, Kilic E, Cam E, Schäbitz WR. Brain Res Bull. 2006 Dec 11;71(1-3):296-300. Epub 2006 Oct 20.
Perspectives on neuroprotective stroke therapy. Schäbitz WR, Fisher M. Biochem Soc Trans. 2006 Dec;34(Pt 6):1271-6. Review.
Granulocyte colony-stimulating factor and acute myocardial infarction. Schäbitz WR, Nikol S, Schneider A. JAMA. 2006 Oct 25;296(16):1967-8; author reply 1968-9. No abstract available.
An extended window of opportunity for G-CSF treatment in cerebral ischemia. Schneider A, Wysocki R, Pitzer C, Krüger C, Laage R, Schwab S, Bach A, Schäbitz WR. BMC Biol. 2006 Oct 18;4:36.
Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Hasselblatt M, Jeibmann A, Riesmeier B, Maintz D, Schäbitz WR. Acta Neuropathol. 2007 Jan;113(1):45-51. Epub 2006 Oct 18.
Chronic renal failure promotes severe variant of vitamin B12 deficiency. Duning T, Nabavi DG, Dziewas R, Kugel H, Schäbitz WR. Eur Neurol. 2006;56(1):62-5. Epub 2006 Aug 17. No abstract available.
Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra. Sommer C, Schomacher M, Berger C, Kuhnert K, Müller HD, Schwab S, Schäbitz WR. Acta Neuropathol. 2006 Sep;112(3):277-86. Epub 2006 Jul 27.
Developing granulocyte-colony stimulating factor for the treatment of stroke: current status of clinical trials. Schäbitz WR, Schneider A. Stroke. 2006 Jul;37(7):1654; author reply 1655. Epub 2006 May 25. No abstract available.
Risperidone attenuates brain damage after focal cerebral ischemia in vivo. Yulug B, Yildiz A, Güzel O, Kilic E, Schäbitz WR, Kilic E. Brain Res Bull. 2006 May 31;69(6):656-9. Epub 2006 Apr 18.
Acute toxic polyradiculopathy after exorbitant intracarotid substance abuse. Kraus J, Baumeier A, Boentert M, Husstedt IW, Nabavi DG, Ringelstein EB, Schäbitz WR. J Neurol. 2006 Jun;253(6):815-6. Epub 2006 Apr 20. No abstract available.
Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH. J Neurochem. 2006 May;97(3):675-86. Epub 2006 Mar 29.
A new model of thromboembolic stroke in the posterior circulation of the rat. Henninger N, Eberius KH, Sicard KM, Kollmar R, Sommer C, Schwab S, Schäbitz WR. J Neurosci Methods. 2006 Sep 30;156(1-2):1-9. Epub 2006 Mar 10.
Long-term gene expression changes in the cortex following cortical ischemia revealed by transcriptional profiling. Krüger C, Cira D, Sommer C, Fischer A, Schäbitz WR, Schneider A. Exp Neurol. 2006 Jul;200(1):135-52. Epub 2006 Mar 10.
Toward a multimodal neuroprotective treatment of stroke. Rogalewski A, Schneider A, Ringelstein EB, Schäbitz WR. Stroke. 2006 Apr;37(4):1129-36. Epub 2006 Mar 9. Review.
A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Schneider A, Kuhn HG, Schäbitz WR. Cell Cycle. 2005 Dec;4(12):1753-7. Epub 2005 Dec 27. Review.
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schäbitz WR. J Clin Invest. 2005 Aug;115(8):2083-98. Epub 2005 Jul 7.
Effects of intracerebroventricular application of brain-derived neurotrophic factor on cerebral recovery after cardiac arrest in rats. Popp E, Padosch SA, Vogel P, Schäbitz WR, Schwab S, Böttiger BW. Crit Care Med. 2004 Sep;32(9 Suppl):S359-65.
Decompressive craniectomy in acute cerebral ischemia in rats. Is there any benefit in smaller thromboembolic infarcts? Engelhorn T, Heiland S, Schabitz WR, Schwab S, Busch E, Forsting M, Doerfler A. Neurosci Lett. 2004 Nov 11;370(2-3):85-90.
Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke - an MRI study. Kollmar R, Henninger N, Bardutzky J, Schellinger PD, Schäbitz WR, Schwab S. Exp Neurol. 2004 Nov;190(1):204-12.
Neuroprotection by hyperbaric oxygenation after experimental focal cerebral ischemia monitored by MRI. Schäbitz WR, Schade H, Heiland S, Kollmar R, Bardutzky J, Henninger N, Müller H, Carl U, Toyokuni S, Sommer C, Schwab S. Stroke. 2004 May;35(5):1175-9. Epub 2004 Apr 1.
Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? Berger C, Schmid PC, Schabitz WR, Wolf M, Schwab S, Schmid HH. J Neurochem. 2004 Mar;88(5):1159-67.
Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Schäbitz WR, Berger C, Kollmar R, Seitz M, Tanay E, Kiessling M, Schwab S, Sommer C. Stroke. 2004 Apr;35(4):992-7. Epub 2004 Feb 26.
High-dose aspirin is neuroprotective in a rat focal ischemia model. Berger C, Xia F, Schabitz WR, Schwab S, Grau A. Brain Res. 2004 Feb 20;998(2):237-42.
Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Berger C, Schabitz WR, Wolf M, Mueller H, Sommer C, Schwab S. Exp Neurol. 2004 Feb;185(2):305-12.
Severe forward flexion of the trunk in Parkinson's disease: focal myopathy of the paraspinal muscles mimicking camptocormia. Schäbitz WR, Glatz K, Schuhan C, Sommer C, Berger C, Schwaninger M, Hartmann M, Hilmar Goebel H, Meinck HM. Mov Disord. 2003 Apr;18(4):408-14.
Exogenous brain-derived neurotrophic factor prevents postischemic downregulation of [3H]muscimol binding to GABA(A) receptors in the cortical penumbra. Sommer C, Kollmar R, Schwab S, Kiessling M, Schäbitz WR. Brain Res Mol Brain Res. 2003 Mar 17;111(1-2):24-30.
Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Schäbitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Schölzke MN, Sommer C, Schwab S. Stroke. 2003 Mar;34(3):745-51. Epub 2003 Feb 13.
[Cerebrotendinous xanthomatosis, a treatable metabolic disorder]. Heller R, Grau AJ, Schäbitz WR, Schwaninger M. Nervenarzt. 2002 Dec;73(12):1160-6. German.
Early effects of acid-base management during hypothermia on cerebral infarct volume, edema, and cerebral blood flow in acute focal cerebral ischemia in rats. Kollmar R, Frietsch T, Georgiadis D, Schäbitz WR, Waschke KF, Kuschinsky W, Schwab S. Anesthesiology. 2002 Oct;97(4):868-74.
Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Schäbitz WR, Giuffrida A, Berger C, Aschoff A, Schwaninger M, Schwab S, Piomelli D. Stroke. 2002 Aug;33(8):2112-4.
Neuroprotective effect of delayed moderate hypothermia after focal cerebral ischemia: an MRI study. Kollmar R, Schäbitz WR, Heiland S, Georgiadis D, Schellinger PD, Bardutzky J, Schwab S. Stroke. 2002 Jul;33(7):1899-904.
Effects of hypothermia on excitatory amino acids and metabolism in stroke patients: a microdialysis study. Berger C, Schäbitz WR, Georgiadis D, Steiner T, Aschoff A, Schwab S. Stroke. 2002 Feb;33(2):519-24.
[Value of MRI in intracerebral and subarachnoid hemorrhage]. Schellinger PD, Fiebach J, Mohr A, Kollmar R, Schwarz S, Schäbitz WR, Sartor K, Hacke W. Nervenarzt. 2001 Dec;72(12):907-17. Review. German.
Neurometabolic changes during treatment with moderate hypothermia in a patient suffering from severe middle cerebral artery infarction. Schäbitz WR, Berger C, Schellinger PD, Aschoff A, Steiner T, Schwab S. Cerebrovasc Dis. 2001;12(4):298-302.
Hypoxic brain damage after intramuscular self-injection of diclofenac for acute back pain. Schäbitz WR, Berger C, Knauth M, Meinck HM, Steiner T. Eur J Anaesthesiol. 2001 Nov;18(11):763-5.
Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri. Schäbitz WR, Hoffmann TT, Heiland S, Kollmar R, Bardutzky J, Sommer C, Schwab S. Stroke. 2001 May;32(5):1226-33.
Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Berger C, Fiorelli M, Steiner T, Schäbitz WR, Bozzao L, Bluhmki E, Hacke W, von Kummer R. Stroke. 2001 Jun;32(6):1330-5.
Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Schäbitz WR, Sommer C, Zoder W, Kiessling M, Schwaninger M, Schwab S. Stroke. 2000 Sep;31(9):2212-7.
The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats. Schäbitz WR, Li F, Fisher M. Stroke. 2000 Jul;31(7):1709-14.
Effect of propentofylline (HWA 285) on focal ischemia in rats: effect of treatment and posttreatment duration on infarct size. Haag P, Schneider T, Schäbitz W, Hacke W. J Neurol Sci. 2000 Apr 1;175(1):52-6.
Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Schäbitz WR, Li F, Irie K, Sandage BW Jr, Locke KW, Fisher M. Stroke. 1999 Feb;30(2):427-31; discussion 431-2.
Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. Schäbitz WR, Schwab S, Spranger M, Hacke W. J Cereb Blood Flow Metab. 1997 May;17(5):500-6.
Decompressive craniectomy in a rat model of "malignant" cerebral hemispheric stroke: experimental support for an aggressive therapeutic approach. Doerfler A, Forsting M, Reith W, Staff C, Heiland S, Schäbitz WR, von Kummer R, Hacke W, Sartor K. J Neurosurg. 1996 Nov;85(5):853-9.
The effects of prolonged treatment with citicoline in temporary experimental focal ischemia. Schäbitz WR, Weber J, Takano K, Sandage BW, Locke KW, Fisher M. J Neurol Sci. 1996 Jun;138(1-2):21-5.
Diffusion weighted imaging for acute cerebral infarction. Schäbitz WR, Fisher M. Neurol Res. 1995 Aug;17(4):270-4. Review.
Decompressive craniectomy for cerebral infarction. An experimental study in rats. Forsting M, Reith W, Schäbitz WR, Heiland S, von Kummer R, Hacke W, Sartor K. Stroke. 1995 Feb;26(2):259-64.